SCHEMBL22153370

SCHEMBL22153370

N#Cc1ccc(-n2c3ccccc3c3c(C#N)cccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
USP14 P54578 4/20 0.40
IMPDH2 P12268 1/20 0.38
RPS6KB1 P23443 1/20 0.36
GSK3B P49841 1/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
SLC22A12 Q96S37 1/20 0.35
TSHR P16473 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SCN9A Q15858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22153413 0.89 ATM (0.55) KDM4EATML3MBTL1IMPDH2ALDH1A1
SCHEMBL23502950 0.89 USP14 (0.38) KDM4EATML3MBTL1USP14IMPDH2
SCHEMBL22153414 0.85 RPS6KB1 (0.40) KDM4EATML3MBTL1IMPDH2RPS6KB1
SCHEMBL21472688 0.85 KDM4E (0.39) KDM4EATML3MBTL1USP14IMPDH2
SCHEMBL21472696 0.85 KDM4E (0.39) KDM4EATML3MBTL1USP14IMPDH2
SCHEMBL21472926 0.85 KDM4E (0.39) KDM4EATML3MBTL1USP14IMPDH2
SCHEMBL23503099 0.84 KDM4E (0.37) KDM4EATML3MBTL1USP14IMPDH2
SCHEMBL23625529 0.84 USP14 (0.44) KDM4EUSP14ALDH1A1MAPT
SCHEMBL3402733 0.84 KDM4E (0.59) KDM4EATML3MBTL1USP14IMPDH2
SCHEMBL30490534 0.84 KDM4E (0.59) KDM4EATML3MBTL1USP14IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KDM4E 3084/4885ATM 994/4885L3MBTL1 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.